Tower Research Capital (TRC)’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $98.2K | Buy |
6,140
+4,273
| +229% | +$68.4K | ﹤0.01% | 2391 |
|
|
2025
Q1 | $31.9K | Sell |
1,867
-14,375
| -89% | -$246K | ﹤0.01% | 2565 |
|
|
2024
Q4 | $402K | Buy |
16,242
+15,226
| +1,499% | +$377K | 0.01% | 1216 |
|
|
2024
Q3 | $29K | Sell |
1,016
-13,126
| -93% | -$374K | ﹤0.01% | 3021 |
|
|
2024
Q2 | $373K | Buy |
14,142
+13,630
| +2,662% | +$360K | 0.01% | 1584 |
|
|
2024
Q1 | $16.5K | Sell |
512
-6,863
| -93% | -$222K | ﹤0.01% | 3172 |
|
|
2023
Q4 | $311K | Sell |
7,375
-2,253
| -23% | -$94.9K | ﹤0.01% | 1751 |
|
|
2023
Q3 | $370K | Buy |
9,628
+7,852
| +442% | +$301K | 0.01% | 1052 |
|
|
2023
Q2 | $33.7K | Sell |
1,776
-19,025
| -91% | -$361K | ﹤0.01% | 2896 |
|
|
2023
Q1 | $322K | Buy |
20,801
+17,554
| +541% | +$272K | 0.01% | 1097 |
|
|
2022
Q4 | $58K | Sell |
3,247
-8,436
| -72% | -$151K | ﹤0.01% | 2238 |
|
|
2022
Q3 | $65K | Buy |
11,683
+5,923
| +103% | +$33K | ﹤0.01% | 2923 |
|
|
2022
Q2 | $22K | Sell |
5,760
-4,670
| -45% | -$17.8K | ﹤0.01% | 3694 |
|
|
2022
Q1 | $57K | Buy |
10,430
+2,492
| +31% | +$13.6K | ﹤0.01% | 2626 |
|
|
2021
Q4 | $67K | Sell |
7,938
-2,349
| -23% | -$19.8K | ﹤0.01% | 2527 |
|
|
2021
Q3 | $89K | Buy |
10,287
+6,200
| +152% | +$53.6K | ﹤0.01% | 2499 |
|
|
2021
Q2 | $43K | Sell |
4,087
-1,659
| -29% | -$17.5K | ﹤0.01% | 3145 |
|
|
2021
Q1 | $92K | Buy |
5,746
+3,296
| +135% | +$52.8K | ﹤0.01% | 2649 |
|
|
2020
Q4 | $113K | Sell |
2,450
-1,496
| -38% | -$69K | ﹤0.01% | 2226 |
|
|
2020
Q3 | $139K | Buy |
3,946
+2,891
| +274% | +$102K | ﹤0.01% | 2887 |
|
|
2020
Q2 | $26K | Buy |
+1,055
| New | +$26K | ﹤0.01% | 3536 |
|